| 000 | 01035 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513231826.0 | ||
| 264 | 0 | _c20010412 | |
| 008 | 200104s 0 0 rus d | ||
| 022 | _a0869-2092 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKulinskiĭ, V I | |
| 245 | 0 | 0 |
_a[Importance of adenosine A2A receptors in resistance to complete global cerebral ischemia]. _h[electronic resource] |
| 260 |
_bEksperimental'naia i klinicheskaia farmakologiia _c |
||
| 300 |
_a9-11 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain Ischemia _xprevention & control |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Agonists |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Antagonists |
| 650 | 0 | 4 | _aReceptor, Adenosine A2A |
| 700 | 1 | _aMinakina, L N | |
| 700 | 1 | _aUsov, L A | |
| 773 | 0 |
_tEksperimental'naia i klinicheskaia farmakologiia _gvol. 63 _gno. 6 _gp. 9-11 |
|
| 999 |
_c11140562 _d11140562 |
||